Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Chubb
Covington
QuintilesIMS
Novartis
Colorcon
McKinsey
Boehringer Ingelheim
US Department of Justice
Julphar

Generated: August 19, 2017

DrugPatentWatch Database Preview

EXELDERM Drug Profile

« Back to Dashboard

Which patents cover Exelderm, and what generic Exelderm alternatives are available?

Exelderm is a drug marketed by Ranbaxy and Sun Pharm Inds Ltd and is included in two NDAs.

The generic ingredient in EXELDERM is sulconazole nitrate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the sulconazole nitrate profile page.

Summary for Tradename: EXELDERM

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list67
Patent Applications: see list513
Drug Prices:see details
DailyMed Link:EXELDERM at DailyMed

Pharmacology for Tradename: EXELDERM

Ingredient-typeAzoles
Drug ClassAzole Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy
EXELDERM
sulconazole nitrate
CREAM;TOPICAL018737-001Feb 28, 1989RXYesYes► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
EXELDERM
sulconazole nitrate
SOLUTION;TOPICAL018738-001Aug 30, 1985RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: EXELDERM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Ltd
EXELDERM
sulconazole nitrate
SOLUTION;TOPICAL018738-001Aug 30, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Federal Trade Commission
US Department of Justice
Fuji
McKinsey
Argus Health
Chinese Patent Office
Fish and Richardson
Dow
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot